Addie Dvir

1.8k total citations
25 papers, 800 citations indexed

About

Addie Dvir is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology. According to data from OpenAlex, Addie Dvir has authored 25 papers receiving a total of 800 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 12 papers in Cancer Research and 10 papers in Oncology. Recurrent topics in Addie Dvir's work include Lung Cancer Treatments and Mutations (13 papers), Cancer Genomics and Diagnostics (12 papers) and Genetic factors in colorectal cancer (3 papers). Addie Dvir is often cited by papers focused on Lung Cancer Treatments and Mutations (13 papers), Cancer Genomics and Diagnostics (12 papers) and Genetic factors in colorectal cancer (3 papers). Addie Dvir collaborates with scholars based in Israel, United States and France. Addie Dvir's co-authors include Lior Soussan‐Gutman, Vincent A. Miller, Nir Peled, Maya Ilouze, Noa Ben-Baruch, Adva Yeheskel, Ido Wolf, Myles Brown, Rinath Jeselsohn and Shulamith Rizel and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Gut.

In The Last Decade

Addie Dvir

23 papers receiving 788 citations

Peers

Addie Dvir

PRM

ONCOL

GENET

Habib Hamidi United States

P. Neven Belgium

D. G. Kieback Germany

Russell Broaddus United States

Eliso Tikishvili United States

Analyn Lizaso China

Garrett Daniels United States

Elisabetta Zulato Italy

Sarab Lizard‐Nacol France

Huawei Zou China

Habib Hamidi United States

Addie Dvir

335 ×0.9

PRM

437 ×1.3

ONCOL

310 ×1.0

685 ×2.3

90 ×0.5

GENET

Citations per year, relative to Addie Dvir Addie Dvir (= 1×) peers Habib Hamidi

Countries citing papers authored by Addie Dvir

Since Specialization

Citations

This map shows the geographic impact of Addie Dvir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Addie Dvir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Addie Dvir more than expected).

Fields of papers citing papers by Addie Dvir

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Addie Dvir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Addie Dvir. The network helps show where Addie Dvir may publish in the future.

Co-authorship network of co-authors of Addie Dvir

This figure shows the co-authorship network connecting the top 25 collaborators of Addie Dvir. A scholar is included among the top collaborators of Addie Dvir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Addie Dvir. Addie Dvir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ofek, Efrat, Rinat Yacobi, Tilda Barliya, et al.. (2023). High-confidence AI-based biomarker profiling for H&E slides to optimize pathology workflow in lung cancer.. Journal of Clinical Oncology. 41(16_suppl). e21207–e21207. 2 indexed citations

Kian, Waleed, Amir Onn, Jair Bar, et al.. (2022). Liquid First Is “Solid” in Naïve Non-Small Cell Lung Cancer Patients: Faster Turnaround Time With High Concordance to Solid Next-Generation Sequencing. Frontiers in Oncology. 12. 912801–912801. 6 indexed citations

Roisman, Laila C., Waleed Kian, Julia Dudnik, et al.. (2021). The impact of osimertinib’ line on clonal evolution in EGFRm NSCLC through NGS-based liquid biopsy and overcoming strategies for resistance. Lung Cancer. 153. 126–133. 16 indexed citations

Peled, Michael, Jair Bar, Sumit Chatterji, et al.. (2020). Early Blood-based Liquid Biopsy in Patients with Treatment-naïve Metastatic Adenocarcinoma of the Lung: A Case Series.. PubMed. 22(12). 784–787. 2 indexed citations

Roisman, Laila C., Martina I. Lefterova, Katie Quinn, et al.. (2019). P1.04-47 Tumor Mutation Burden Through Hybrid Capture – Circulating Tumor DNA May Predict Response to Immunotherapy in NSCLC. Journal of Thoracic Oncology. 14(10). S459–S459.

Dvir, Addie, Lior Soussan‐Gutman, Maya Ilouze, et al.. (2018). The Clinical Impact of Comprehensive Genomic Testing of Circulating Cell-Free DNA in Advanced Lung Cancer. Journal of Thoracic Oncology. 13(11). 1705–1716. 40 indexed citations

Ilouze, Maya, Laila C. Roisman, Addie Dvir, et al.. (2017). P2.03b-047 The Clinical Impact of Multiplex ctDNA Gene Analysis in Lung Cancer. Journal of Thoracic Oncology. 12(1). S964–S964. 1 indexed citations

Peled, Nir, Laila C. Roisman, Benjamin Miron, et al.. (2017). Subclonal Therapy by Two EGFR TKIs Guided by Sequential Plasma Cell-free DNA in EGFR -Mutated Lung Cancer. Journal of Thoracic Oncology. 12(7). e81–e84. 40 indexed citations

Ilouze, Maya, et al.. (2016). Clinical Impact of Hybrid Capture–Based Next-Generation Sequencing on Changes in Treatment Decisions in Lung Cancer. Journal of Thoracic Oncology. 12(2). 258–268. 59 indexed citations

10.

Blumenthal, Deborah T., Addie Dvir, Alexander Lossos, et al.. (2016). Clinical utility and treatment outcome of comprehensive genomic profiling in high grade glioma patients. Journal of Neuro-Oncology. 130(1). 211–219. 31 indexed citations

11.

Paluch–Shimon, Shani, Addie Dvir, Luna Kadouri, et al.. (2015). Screening for germline mutations in breast/ovarian cancer susceptibility genes in high-risk families in Israel. Breast Cancer Research and Treatment. 155(1). 133–138. 17 indexed citations

12.

Friedman, Eitan, Noa Efrat, Lior Soussan‐Gutman, et al.. (2015). Low-level constitutional mosaicism of a de novoBRCA1 gene mutation. British Journal of Cancer. 112(4). 765–768. 21 indexed citations

13.

Epelbaum, Ron, Einat Shacham‐Shmueli, Baruch Klein, et al.. (2015). Molecular Profiling-Selected Therapy for Treatment of Advanced Pancreaticobiliary Cancer: A Retrospective Multicenter Study. BioMed Research International. 2015. 1–9. 7 indexed citations

14.

Popovtzer, Aron, Michal Sarfaty, Dror Limon, et al.. (2015). Metastatic Salivary Gland Tumors: A Single-Center Study Demonstrating the Feasibility and Potential Clinical Benefit of Molecular-Profiling-Guided Therapy. BioMed Research International. 2015. 1–7. 12 indexed citations

15.

Agbarya, Abed, et al.. (2014). Hormone dependent metastatic salivary gland carcinoma: a case report. SpringerPlus. 3(1). 363–363. 5 indexed citations

16.

Merenbakh-Lamin, Keren, Noa Ben-Baruch, Adva Yeheskel, et al.. (2013). D538G Mutation in Estrogen Receptor-α: A Novel Mechanism for Acquired Endocrine Resistance in Breast Cancer. Cancer Research. 73(23). 6856–6864. 290 indexed citations

17.

Shlomi, Dekel, Amir Onn, Maya Gottfried, et al.. (2013). Better Selection Model for EML4-ALK Fusion Gene Test in Patients with Non-Small-Cell Lung Cancer. Journal of Cancer Therapy. 4(8). 54–58. 3 indexed citations

18.

Levi, Zohar, Aviv Shaish, Niva Yacov, et al.. (2003). Rosiglitazone (PPARγ‐agonist) attenuates atherogenesis with no effect on hyperglycaemia in a combined diabetes–atherosclerosis mouse model. Diabetes Obesity and Metabolism. 5(1). 45–50. 64 indexed citations

19.

Dvir, Addie, et al.. (2001). Brachial plexus injury and obstetrical risk factors. International Journal of Gynecology & Obstetrics. 73(1). 21–25. 29 indexed citations

20.

Halpern, Zamir, et al.. (1992). Effect of lipid infusion on bile composition and lithogenicity in patients without cholesterol gall stones.. Gut. 33(10). 1400–1403. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact